Aurobindo`s Divestiture of Natrol

Code : MAA0227

Year : 2021

Industry : -

Region : -

Teaching Note:Available

Structured Assignment :Not Available

Buy This Case Study        

Abstract: India-based Aurobindo Pharma Limited (Aurobindo) is a leading Indian multinational pharmaceutical company. In the month of October 2020, Aurobindo announced the divestiture of its US subsidiary Natrol Inc. to an investment management company for US$ 550 million (Rs. 40,480 million). The deal was expected to provide a strategic advantage to Aurobindo by improving its financial position and also to help it focus on strategic acquisitions and research and development activities. The present case can be used to discuss the Indian pharmaceutical industry and the investment strategies of the pharma players in India, and also discuss the concepts of mergers and acquisitions, divestitures, and leverages in the context of the Natrol divestiture.

For Case Books Click Here >>

For Case eBooks Click Here >>

Pedagogical Objectives:

  • Divestiture and Liquidation Strategy.
  • Corporate Restructuring Strategy.
  • Features and scope of Indian Pharma Industry.
  • Diversification Strategy.
  • Leverages and Types of Leverages.


    Keywords : Divesiture; Aurobindo Pharma; Natrol; Leverage; Mergers and Acquisitions; Diversification; Liquidation; Restructuring Strategy; India Pharmaccumulated losses, Deep discount strategy


    Case Introduction >>